Overview

Hydroquinidine Versus Placebo in Patients With Brugada Syndrome

Status:
Terminated
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
The specific aim of this study is to determine whether hydroquinidine administration can prevent heart from appearance of ventricular arrhythmia detected by the automatic implantable defibrillator (ICD).
Phase:
Phase 3
Details
Lead Sponsor:
Nantes University Hospital
Collaborator:
Sanofi
Treatments:
Hydroquinidine
Quinidine